Global Pneumococcal Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
Summary
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, The global Pneumococcal Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pneumococcal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pneumococcal Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumococcal Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pneumococcal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pneumococcal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pneumococcal Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pneumococcal Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pneumococcal Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, The global Pneumococcal Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pneumococcal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pneumococcal Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumococcal Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pneumococcal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pneumococcal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pneumococcal Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pneumococcal Vaccine segment by Company
- Pfizer
- GSK
- MSD
- Sanofipasteur
- CDIBP
- PPSV 23
- PCV 7/13
- PCV 10
- Child
- Adult
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pneumococcal Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2019-2030).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Pneumococcal Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Pneumococcal Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Pneumococcal Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Pneumococcal Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL PNEUMOCOCCAL VACCINE MARKET DYNAMICS
2.1 Pneumococcal Vaccine Industry Trends
2.2 Pneumococcal Vaccine Industry Drivers
2.3 Pneumococcal Vaccine Industry Opportunities and Challenges
2.4 Pneumococcal Vaccine Industry Restraints
3 PNEUMOCOCCAL VACCINE MARKET BY MANUFACTURERS
3.1 Global Pneumococcal Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Pneumococcal Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Pneumococcal Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Pneumococcal Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Pneumococcal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pneumococcal Vaccine Manufacturers, Product Type & Application
3.7 Global Pneumococcal Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Pneumococcal Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Pneumococcal Vaccine Tier 1, Tier 2, and Tier
4 PNEUMOCOCCAL VACCINE MARKET BY TYPE
4.1 Pneumococcal Vaccine Type Introduction
4.1.1 PPSV
4.1.2 PCV 7/13
4.1.3 PCV
4.2 Global Pneumococcal Vaccine Sales by Type
4.2.1 Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pneumococcal Vaccine Sales by Type (2019-2030)
4.2.3 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Pneumococcal Vaccine Revenue by Type
4.3.1 Global Pneumococcal Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Pneumococcal Vaccine Revenue by Type (2019-2030)
4.3.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
5 PNEUMOCOCCAL VACCINE MARKET BY APPLICATION
5.1 Pneumococcal Vaccine Application Introduction
5.1.1 Child
5.1.2 Adult
5.2 Global Pneumococcal Vaccine Sales by Application
5.2.1 Global Pneumococcal Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pneumococcal Vaccine Sales by Application (2019-2030)
5.2.3 Global Pneumococcal Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Pneumococcal Vaccine Revenue by Application
5.3.1 Global Pneumococcal Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Pneumococcal Vaccine Revenue by Application (2019-2030)
5.3.3 Global Pneumococcal Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL PNEUMOCOCCAL VACCINE SALES BY REGION
6.1 Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Pneumococcal Vaccine Sales by Region (2019-2030)
6.2.1 Global Pneumococcal Vaccine Sales by Region (2019-2024)
6.2.2 Global Pneumococcal Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Pneumococcal Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Pneumococcal Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Pneumococcal Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Pneumococcal Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL PNEUMOCOCCAL VACCINE REVENUE BY REGION
7.1 Global Pneumococcal Vaccine Revenue by Region
7.1.1 Global Pneumococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Pneumococcal Vaccine Revenue by Region (2019-2024)
7.1.3 Global Pneumococcal Vaccine Revenue by Region (2025-2030)
7.1.4 Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Pneumococcal Vaccine Revenue (2019-2030)
7.2.2 North America Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Pneumococcal Vaccine Revenue (2019-2030)
7.3.2 Europe Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pneumococcal Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Pneumococcal Vaccine Revenue (2019-2030)
7.5.2 LAMEA Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Pfizer
8.1.1 Pfizer Comapny Information
8.1.2 Pfizer Business Overview
8.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
8.1.5 Pfizer Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Pneumococcal Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 MSD
8.3.1 MSD Comapny Information
8.3.2 MSD Business Overview
8.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 MSD Pneumococcal Vaccine Product Portfolio
8.3.5 MSD Recent Developments
8.4 Sanofipasteur
8.4.1 Sanofipasteur Comapny Information
8.4.2 Sanofipasteur Business Overview
8.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
8.4.5 Sanofipasteur Recent Developments
8.5 CDIBP
8.5.1 CDIBP Comapny Information
8.5.2 CDIBP Business Overview
8.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
8.5.5 CDIBP Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Pneumococcal Vaccine Value Chain Analysis
9.1.1 Pneumococcal Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pneumococcal Vaccine Production Mode & Process
9.2 Pneumococcal Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pneumococcal Vaccine Distributors
9.2.3 Pneumococcal Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Pneumococcal Vaccine Market Size, 2019 VS 2023 VS 2030
1.3 Global Pneumococcal Vaccine Market Size Estimates and Forecasts (2019-2030)
1.4 Global Pneumococcal Vaccine Sales Estimates and Forecasts (2019-2030)
1.5 Global Pneumococcal Vaccine Market Average Price (2019-2030)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 GLOBAL PNEUMOCOCCAL VACCINE MARKET DYNAMICS
2.1 Pneumococcal Vaccine Industry Trends
2.2 Pneumococcal Vaccine Industry Drivers
2.3 Pneumococcal Vaccine Industry Opportunities and Challenges
2.4 Pneumococcal Vaccine Industry Restraints
3 PNEUMOCOCCAL VACCINE MARKET BY MANUFACTURERS
3.1 Global Pneumococcal Vaccine Revenue by Manufacturers (2019-2024)
3.2 Global Pneumococcal Vaccine Sales by Manufacturers (2019-2024)
3.3 Global Pneumococcal Vaccine Average Sales Price by Manufacturers (2019-2024)
3.4 Global Pneumococcal Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Pneumococcal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pneumococcal Vaccine Manufacturers, Product Type & Application
3.7 Global Pneumococcal Vaccine Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Pneumococcal Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2023
3.8.3 2023 Pneumococcal Vaccine Tier 1, Tier 2, and Tier
4 PNEUMOCOCCAL VACCINE MARKET BY TYPE
4.1 Pneumococcal Vaccine Type Introduction
4.1.1 PPSV
4.1.2 PCV 7/13
4.1.3 PCV
4.2 Global Pneumococcal Vaccine Sales by Type
4.2.1 Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pneumococcal Vaccine Sales by Type (2019-2030)
4.2.3 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
4.3 Global Pneumococcal Vaccine Revenue by Type
4.3.1 Global Pneumococcal Vaccine Revenue by Type (2019 VS 2023 VS 2030)
4.3.2 Global Pneumococcal Vaccine Revenue by Type (2019-2030)
4.3.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
5 PNEUMOCOCCAL VACCINE MARKET BY APPLICATION
5.1 Pneumococcal Vaccine Application Introduction
5.1.1 Child
5.1.2 Adult
5.2 Global Pneumococcal Vaccine Sales by Application
5.2.1 Global Pneumococcal Vaccine Sales by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pneumococcal Vaccine Sales by Application (2019-2030)
5.2.3 Global Pneumococcal Vaccine Sales Market Share by Application (2019-2030)
5.3 Global Pneumococcal Vaccine Revenue by Application
5.3.1 Global Pneumococcal Vaccine Revenue by Application (2019 VS 2023 VS 2030)
5.3.2 Global Pneumococcal Vaccine Revenue by Application (2019-2030)
5.3.3 Global Pneumococcal Vaccine Revenue Market Share by Application (2019-2030)
6 GLOBAL PNEUMOCOCCAL VACCINE SALES BY REGION
6.1 Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Pneumococcal Vaccine Sales by Region (2019-2030)
6.2.1 Global Pneumococcal Vaccine Sales by Region (2019-2024)
6.2.2 Global Pneumococcal Vaccine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.3.2 North America Pneumococcal Vaccine Sales by Country (2019-2030)
6.3.3 U.S.
6.3.4 Canada
6.4 Europe
6.4.1 Europe Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.4.2 Europe Pneumococcal Vaccine Sales by Country (2019-2030)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.5.2 Asia Pacific Pneumococcal Vaccine Sales by Country (2019-2030)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 LAMEA
6.6.1 LAMEA Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030
6.6.2 LAMEA Pneumococcal Vaccine Sales by Country (2019-2030)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.6 GCC Countries
7 GLOBAL PNEUMOCOCCAL VACCINE REVENUE BY REGION
7.1 Global Pneumococcal Vaccine Revenue by Region
7.1.1 Global Pneumococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030
7.1.2 Global Pneumococcal Vaccine Revenue by Region (2019-2024)
7.1.3 Global Pneumococcal Vaccine Revenue by Region (2025-2030)
7.1.4 Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2030)
7.2 North America
7.2.1 North America Pneumococcal Vaccine Revenue (2019-2030)
7.2.2 North America Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.3 Europe
7.3.1 Europe Pneumococcal Vaccine Revenue (2019-2030)
7.3.2 Europe Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pneumococcal Vaccine Revenue (2019-2030)
7.4.2 Asia-Pacific Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
7.5 LAMEA
7.5.1 LAMEA Pneumococcal Vaccine Revenue (2019-2030)
7.5.2 LAMEA Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
8 COMPANY PROFILES
8.1 Pfizer
8.1.1 Pfizer Comapny Information
8.1.2 Pfizer Business Overview
8.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
8.1.5 Pfizer Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.2.4 GSK Pneumococcal Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 MSD
8.3.1 MSD Comapny Information
8.3.2 MSD Business Overview
8.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.3.4 MSD Pneumococcal Vaccine Product Portfolio
8.3.5 MSD Recent Developments
8.4 Sanofipasteur
8.4.1 Sanofipasteur Comapny Information
8.4.2 Sanofipasteur Business Overview
8.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
8.4.5 Sanofipasteur Recent Developments
8.5 CDIBP
8.5.1 CDIBP Comapny Information
8.5.2 CDIBP Business Overview
8.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
8.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
8.5.5 CDIBP Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Pneumococcal Vaccine Value Chain Analysis
9.1.1 Pneumococcal Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pneumococcal Vaccine Production Mode & Process
9.2 Pneumococcal Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pneumococcal Vaccine Distributors
9.2.3 Pneumococcal Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
LIST OF TABLES
Table 1. Pneumococcal Vaccine Industry Trends
Table 2. Pneumococcal Vaccine Industry Drivers
Table 3. Pneumococcal Vaccine Industry Opportunities and Challenges
Table 4. Pneumococcal Vaccine Industry Restraints
Table 5. Global Pneumococcal Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Pneumococcal Vaccine Sales by Manufacturers (K Doses) & (2019-2024)
Table 8. Global Pneumococcal Vaccine Sales Market Share by Manufacturers
Table 9. Global Pneumococcal Vaccine Average Sales Price (USD/Dose) of Manufacturers (2019-2024)
Table 10. Global Pneumococcal Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Pneumococcal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Pneumococcal Vaccine Manufacturers, Product Type & Application
Table 13. Global Pneumococcal Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pneumococcal Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of PPSV 23
Table 17. Major Manufacturers of PCV 7/13
Table 18. Major Manufacturers of PCV 10
Table 19. Global Pneumococcal Vaccine Sales by Type 2019 VS 2023 VS 2030 (K Doses)
Table 20. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 21. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 22. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Table 23. Global Pneumococcal Vaccine Sales Market Share by Type (2025-2030)
Table 24. Global Pneumococcal Vaccine Revenue by Type 2019 VS 2023 VS 2030 (K Doses)
Table 25. Global Pneumococcal Vaccine Revenue by Type (2019-2024) & (K Doses)
Table 26. Global Pneumococcal Vaccine Revenue by Type (2025-2030) & (K Doses)
Table 27. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2024)
Table 28. Global Pneumococcal Vaccine Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Child
Table 30. Major Manufacturers of Adult
Table 31. Global Pneumococcal Vaccine Sales by Application 2019 VS 2023 VS 2030 (K Doses)
Table 32. Global Pneumococcal Vaccine Sales by Application (2019-2024) & (K Doses)
Table 33. Global Pneumococcal Vaccine Sales by Application (2025-2030) & (K Doses)
Table 34. Global Pneumococcal Vaccine Sales Market Share by Application (2019-2024)
Table 35. Global Pneumococcal Vaccine Sales Market Share by Application (2025-2030)
Table 36. Global Pneumococcal Vaccine Revenue by Application 2019 VS 2023 VS 2030 (K Doses)
Table 37. Global Pneumococcal Vaccine Revenue by Application (2019-2024) & (K Doses)
Table 38. Global Pneumococcal Vaccine Revenue by Application (2025-2030) & (K Doses)
Table 39. Global Pneumococcal Vaccine Revenue Market Share by Application (2019-2024)
Table 40. Global Pneumococcal Vaccine Revenue Market Share by Application (2025-2030)
Table 41. Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030 (K Doses)
Table 42. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 43. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2024)
Table 44. Global Pneumococcal Vaccine Sales Forecasted by Region (2025-2030) & (K Doses)
Table 45. Global Pneumococcal Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 47. North America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 48. North America Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 49. Europe Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 50. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 51. Europe Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 52. Asia Pacific Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 53. Asia Pacific Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 54. Asia Pacific Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 55. LAMEA Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 56. LAMEA Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 57. LAMEA Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 58. Global Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Pneumococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Pneumococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 62. Global Pneumococcal Vaccine Revenue Market Share by Region (2025-2030)
Table 63. Pfizer Company Information
Table 64. Pfizer Business Overview
Table 65. Pfizer Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. Pfizer Pneumococcal Vaccine Product Portfolio
Table 67. Pfizer Recent Development
Table 68. GSK Company Information
Table 69. GSK Business Overview
Table 70. GSK Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. GSK Pneumococcal Vaccine Product Portfolio
Table 72. GSK Recent Development
Table 73. MSD Company Information
Table 74. MSD Business Overview
Table 75. MSD Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. MSD Pneumococcal Vaccine Product Portfolio
Table 77. MSD Recent Development
Table 78. Sanofipasteur Company Information
Table 79. Sanofipasteur Business Overview
Table 80. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 82. Sanofipasteur Recent Development
Table 83. CDIBP Company Information
Table 84. CDIBP Business Overview
Table 85. CDIBP Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. CDIBP Pneumococcal Vaccine Product Portfolio
Table 87. CDIBP Recent Development
Table 88. Key Raw Materials
Table 89. Raw Materials Key Suppliers
Table 90. Pneumococcal Vaccine Distributors List
Table 91. Pneumococcal Vaccine Customers List
Table 92. Research Programs/Design for This Report
Table 93. Authors List of This Report
Table 94. Secondary Sources
Table 95. Primary Sources
Table 1. Pneumococcal Vaccine Industry Trends
Table 2. Pneumococcal Vaccine Industry Drivers
Table 3. Pneumococcal Vaccine Industry Opportunities and Challenges
Table 4. Pneumococcal Vaccine Industry Restraints
Table 5. Global Pneumococcal Vaccine Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 6. Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
Table 7. Global Pneumococcal Vaccine Sales by Manufacturers (K Doses) & (2019-2024)
Table 8. Global Pneumococcal Vaccine Sales Market Share by Manufacturers
Table 9. Global Pneumococcal Vaccine Average Sales Price (USD/Dose) of Manufacturers (2019-2024)
Table 10. Global Pneumococcal Vaccine Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Pneumococcal Vaccine Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Pneumococcal Vaccine Manufacturers, Product Type & Application
Table 13. Global Pneumococcal Vaccine Manufacturers Commercialization Time
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pneumococcal Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 16. Major Manufacturers of PPSV 23
Table 17. Major Manufacturers of PCV 7/13
Table 18. Major Manufacturers of PCV 10
Table 19. Global Pneumococcal Vaccine Sales by Type 2019 VS 2023 VS 2030 (K Doses)
Table 20. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)
Table 21. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)
Table 22. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2024)
Table 23. Global Pneumococcal Vaccine Sales Market Share by Type (2025-2030)
Table 24. Global Pneumococcal Vaccine Revenue by Type 2019 VS 2023 VS 2030 (K Doses)
Table 25. Global Pneumococcal Vaccine Revenue by Type (2019-2024) & (K Doses)
Table 26. Global Pneumococcal Vaccine Revenue by Type (2025-2030) & (K Doses)
Table 27. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2024)
Table 28. Global Pneumococcal Vaccine Revenue Market Share by Type (2025-2030)
Table 29. Major Manufacturers of Child
Table 30. Major Manufacturers of Adult
Table 31. Global Pneumococcal Vaccine Sales by Application 2019 VS 2023 VS 2030 (K Doses)
Table 32. Global Pneumococcal Vaccine Sales by Application (2019-2024) & (K Doses)
Table 33. Global Pneumococcal Vaccine Sales by Application (2025-2030) & (K Doses)
Table 34. Global Pneumococcal Vaccine Sales Market Share by Application (2019-2024)
Table 35. Global Pneumococcal Vaccine Sales Market Share by Application (2025-2030)
Table 36. Global Pneumococcal Vaccine Revenue by Application 2019 VS 2023 VS 2030 (K Doses)
Table 37. Global Pneumococcal Vaccine Revenue by Application (2019-2024) & (K Doses)
Table 38. Global Pneumococcal Vaccine Revenue by Application (2025-2030) & (K Doses)
Table 39. Global Pneumococcal Vaccine Revenue Market Share by Application (2019-2024)
Table 40. Global Pneumococcal Vaccine Revenue Market Share by Application (2025-2030)
Table 41. Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030 (K Doses)
Table 42. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 43. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2024)
Table 44. Global Pneumococcal Vaccine Sales Forecasted by Region (2025-2030) & (K Doses)
Table 45. Global Pneumococcal Vaccine Sales Forecasted Market Share by Region (2025-2030)
Table 46. North America Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 47. North America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 48. North America Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 49. Europe Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 50. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 51. Europe Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 52. Asia Pacific Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 53. Asia Pacific Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 54. Asia Pacific Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 55. LAMEA Pneumococcal Vaccine Sales Growth Rate by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 56. LAMEA Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 57. LAMEA Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 58. Global Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. Global Pneumococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 60. Global Pneumococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 61. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2024)
Table 62. Global Pneumococcal Vaccine Revenue Market Share by Region (2025-2030)
Table 63. Pfizer Company Information
Table 64. Pfizer Business Overview
Table 65. Pfizer Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 66. Pfizer Pneumococcal Vaccine Product Portfolio
Table 67. Pfizer Recent Development
Table 68. GSK Company Information
Table 69. GSK Business Overview
Table 70. GSK Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 71. GSK Pneumococcal Vaccine Product Portfolio
Table 72. GSK Recent Development
Table 73. MSD Company Information
Table 74. MSD Business Overview
Table 75. MSD Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 76. MSD Pneumococcal Vaccine Product Portfolio
Table 77. MSD Recent Development
Table 78. Sanofipasteur Company Information
Table 79. Sanofipasteur Business Overview
Table 80. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 81. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 82. Sanofipasteur Recent Development
Table 83. CDIBP Company Information
Table 84. CDIBP Business Overview
Table 85. CDIBP Pneumococcal Vaccine Sales (K Doses), Price (USD/Dose), Revenue (US$ Million) and Gross Margin (2019-2024)
Table 86. CDIBP Pneumococcal Vaccine Product Portfolio
Table 87. CDIBP Recent Development
Table 88. Key Raw Materials
Table 89. Raw Materials Key Suppliers
Table 90. Pneumococcal Vaccine Distributors List
Table 91. Pneumococcal Vaccine Customers List
Table 92. Research Programs/Design for This Report
Table 93. Authors List of This Report
Table 94. Secondary Sources
Table 95. Primary Sources
LIST OF FIGURES
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pneumococcal Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pneumococcal Vaccine Sales (2019-2030) & (K Doses)
Figure 5. Global Pneumococcal Vaccine Average Price (USD/Dose) & (2019-2030)
Figure 6. Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. PPSV 23 Picture
Figure 9. PCV 7/13 Picture
Figure 10. PCV 10 Picture
Figure 11. Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 12. Global Pneumococcal Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 14. Global Pneumococcal Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 15. Global Pneumococcal Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 17. Child Picture
Figure 18. Adult Picture
Figure 19. Global Pneumococcal Vaccine Sales by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 20. Global Pneumococcal Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Pneumococcal Vaccine Sales Market Share by Application (2019-2030)
Figure 22. Global Pneumococcal Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 23. Global Pneumococcal Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Pneumococcal Vaccine Revenue Market Share by Application (2019-2030)
Figure 25. North America Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 26. North America Pneumococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 27. U.S. Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 28. Canada Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 29. Europe Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 30. Europe Pneumococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 31. Germany Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 32. France Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 33. U.K. Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 34. Italy Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 35. Netherlands Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 36. Asia Pacific Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 37. Asia Pacific Pneumococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 38. China Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 39. Japan Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 40. South Korea Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 41. Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 42. India Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 43. Australia Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 44. LAMEA Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 45. LAMEA Pneumococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Mexico Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 47. Brazil Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 48. Turkey Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 49. GCC Countries Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 50. Global Pneumococcal Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Pneumococcal Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. North America Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Pneumococcal Vaccine Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Pneumococcal Vaccine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pneumococcal Vaccine Market Size (2019-2030) & (US$ Million)
Figure 4. Global Pneumococcal Vaccine Sales (2019-2030) & (K Doses)
Figure 5. Global Pneumococcal Vaccine Average Price (USD/Dose) & (2019-2030)
Figure 6. Global Top 5 and 10 Pneumococcal Vaccine Players Market Share by Revenue in 2023
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. PPSV 23 Picture
Figure 9. PCV 7/13 Picture
Figure 10. PCV 10 Picture
Figure 11. Global Pneumococcal Vaccine Sales by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 12. Global Pneumococcal Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 13. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)
Figure 14. Global Pneumococcal Vaccine Revenue by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 15. Global Pneumococcal Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 16. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)
Figure 17. Child Picture
Figure 18. Adult Picture
Figure 19. Global Pneumococcal Vaccine Sales by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 20. Global Pneumococcal Vaccine Sales Market Share 2019 VS 2023 VS 2030
Figure 21. Global Pneumococcal Vaccine Sales Market Share by Application (2019-2030)
Figure 22. Global Pneumococcal Vaccine Revenue by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 23. Global Pneumococcal Vaccine Revenue Market Share 2019 VS 2023 VS 2030
Figure 24. Global Pneumococcal Vaccine Revenue Market Share by Application (2019-2030)
Figure 25. North America Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 26. North America Pneumococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 27. U.S. Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 28. Canada Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 29. Europe Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 30. Europe Pneumococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 31. Germany Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 32. France Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 33. U.K. Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 34. Italy Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 35. Netherlands Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 36. Asia Pacific Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 37. Asia Pacific Pneumococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 38. China Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 39. Japan Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 40. South Korea Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 41. Southeast Asia Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 42. India Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 43. Australia Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 44. LAMEA Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 45. LAMEA Pneumococcal Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Mexico Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 47. Brazil Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 48. Turkey Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 49. GCC Countries Pneumococcal Vaccine Sales and Growth Rate (2019-2030) & (K Doses)
Figure 50. Global Pneumococcal Vaccine Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 51. Global Pneumococcal Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 52. North America Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 53. North America Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 54. Europe Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 55. Europe Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 56. Asia-Pacific Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 57. Asia-Pacific Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 58. LAMEA Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)
Figure 59. LAMEA Pneumococcal Vaccine Revenue Share by Country: 2019 VS 2023 VS 2030
Figure 60. Pneumococcal Vaccine Value Chain
Figure 61. Manufacturing Cost Structure
Figure 62. Pneumococcal Vaccine Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Years Considered
Figure 66. Research Process
Figure 67. Key Executives Interviewed
